Evolutionary trajectory of SARS-CoV-2 and emerging variants

被引:0
|
作者
Jalen Singh
Pranav Pandit
Andrew G. McArthur
Arinjay Banerjee
Karen Mossman
机构
[1] McMaster University,School of Interdisciplinary Science
[2] University of California Davis,EpiCenter for Disease Dynamics, One Health Institute, School of Veterinary Medicine
[3] McMaster University,Department of Biochemistry and Biomedical Sciences
[4] McMaster University,Michael G. DeGroote Institute for Infectious Disease Research
[5] University of Saskatchewan,Vaccine and Infectious Disease Organization
[6] University of Saskatchewan,Department of Veterinary Microbiology, Western College of Veterinary Medicine
[7] University of Waterloo,Department of Biology
[8] McMaster University,Department of Medicine
[9] McMaster University,McMaster Immunology Research Centre
来源
关键词
SARS-CoV-2; Coronavirus; Evolution; Mutations; Selection; Variants;
D O I
暂无
中图分类号
学科分类号
摘要
The emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and more recently, the independent evolution of multiple SARS-CoV-2 variants has generated renewed interest in virus evolution and cross-species transmission. While all known human coronaviruses (HCoVs) are speculated to have originated in animals, very little is known about their evolutionary history and factors that enable some CoVs to co-exist with humans as low pathogenic and endemic infections (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1), while others, such as SARS-CoV, MERS-CoV and SARS-CoV-2 have evolved to cause severe disease. In this review, we highlight the origins of all known HCoVs and map positively selected for mutations within HCoV proteins to discuss the evolutionary trajectory of SARS-CoV-2. Furthermore, we discuss emerging mutations within SARS-CoV-2 and variants of concern (VOC), along with highlighting the demonstrated or speculated impact of these mutations on virus transmission, pathogenicity, and neutralization by natural or vaccine-mediated immunity.
引用
收藏
相关论文
共 50 条
  • [41] How will emerging SARS-CoV-2 variants impact herd immunity?
    Lippi, Giuseppe
    Henry, Brandon M.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [42] Emerging SARS-CoV-2 variants of concern and potential intervention approaches
    Khateeb, Jasmin
    Li, Yuchong
    Zhang, Haibo
    [J]. CRITICAL CARE, 2021, 25 (01)
  • [43] SARS-CoV-2 variants of concern-An emerging global threat
    Sree, P. Charulata
    Kandi, Venkata Ramana
    Suvvari, Tarun Kumar
    [J]. INDIAN JOURNAL OF RESPIRATORY CARE, 2022, 11 (01) : 83 - 84
  • [44] Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control
    Neuzil, Kathleen M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20): : 1952 - 1954
  • [45] SARS-CoV-2 emerging variants in Africa: view from Gabon
    Zoa-Assoumou, Samira
    Ndeboko, Benedicte
    Manouana, Gedeon Prince
    Houechenou, Rotimi Myrabelle Avome
    Bikangui, Rodrigue
    Mveang-Nzoghe, Amandine
    Ondo, Georgelin Nguema
    Mbongo-Kama, Elvyre
    Lell, Bertrand
    Abe, Haruka
    Ushijima, Yuri
    Antchouey, Anne-Marie
    Yasuda, Jiro
    Adegnika, Ayola Akim
    Siawaya, Joel Fleury Djoba
    [J]. LANCET MICROBE, 2021, 2 (08): : E349 - E349
  • [46] Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
    Skelly, Donal T.
    Harding, Adam C.
    Gilbert-Jaramillo, Javier
    Knight, Michael L.
    Longet, Stephanie
    Brown, Anthony
    Adele, Sandra
    Adland, Emily
    Brown, Helen
    Chinnakannan, Senthil
    Chinnakannan, Senthil
    Donnison, Timothy
    Ali, Mohammad
    Rongkard, Patpong
    Pace, Matthew
    Zacharopoulou, Peny
    Robinson, Nicola
    Csala, Anna
    De Lara, Cathy
    Hutchings, Claire L.
    Mehta, Hema
    Lee, Lian Ni
    Edmans, Matthew
    Hackstein, Carl-Philipp
    Phalora, Prabhjeet
    Li, Wenqin
    Phillips, Eloise
    Malone, Tom
    Ogbe, Ane
    Jay, Cecilia
    Tipoe, Timothy
    Tipton, Tom
    Stafford, Lizzie
    Mentzer, Alexander J.
    Johnson, Sile A.
    Amini, Ali
    Marjot, Thomas
    Marjot, Thomas
    Dimitriadis, Stavros
    Simmons, Beatrice
    Deeks, Alexandra
    Kerneis, Sven
    Abuelgasim, Hibatullah
    Wilson, Robert
    Thomas, Sarah R.
    Watson, Adam
    Alhussni, Ahmed
    Cutteridge, Joseph
    Weeks, Esme
    Denly, Lucy
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [47] Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
    Donal T. Skelly
    Adam C. Harding
    Javier Gilbert-Jaramillo
    Michael L. Knight
    Stephanie Longet
    Anthony Brown
    Sandra Adele
    Emily Adland
    Helen Brown
    Tom Tipton
    Lizzie Stafford
    Alexander J. Mentzer
    Síle A. Johnson
    Ali Amini
    Tiong Kit Tan
    Lisa Schimanski
    Kuan-Ying A. Huang
    Pramila Rijal
    John Frater
    Philip Goulder
    Christopher P. Conlon
    Katie Jeffery
    Christina Dold
    Andrew J. Pollard
    Alex Sigal
    Tulio de Oliveira
    Alain R. Townsend
    Paul Klenerman
    Susanna J. Dunachie
    Eleanor Barnes
    Miles W. Carroll
    William S. James
    [J]. Nature Communications, 12
  • [48] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
    Gomez, Carmen Elena
    Perdiguero, Beatriz
    Esteban, Mariano
    [J]. VACCINES, 2021, 9 (03) : 1 - 13
  • [49] Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak
    Metcalf, C. Jessica E.
    Viboud, Cecile
    Spiro, David J.
    Grenfell, Bryan T.
    [J]. TRENDS IN IMMUNOLOGY, 2020, 41 (10) : 849 - 851
  • [50] The SARS-CoV-2 Variants and their Impacts
    Shukri, Amir Muhaimin Akmal
    Wang, Seok Mui
    Chia, Suet Lin
    Nawi, Siti Farah Alwani Mohd
    [J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (03): : 1409 - 1424